US Stock MarketDetailed Quotes

ALT Altimmune

Watchlist
  • 8.000
  • +0.450+5.96%
Close Dec 26 16:00 ET
  • 7.870
  • -0.130-1.63%
Pre 06:18 ET
569.00MMarket Cap-5.10P/E (TTM)

Altimmune Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-32.37%-27.12M
6.58%-18.11M
15.72%-16.36M
-21.13%-75.81M
4.47%-16.53M
-36.13%-20.49M
-16.04%-19.38M
-43.48%-19.41M
20.01%-62.59M
21.22%-17.31M
Net income from continuing operations
-10.52%-22.85M
-53.42%-24.64M
-21.52%-24.39M
-4.41%-88.45M
-46.08%-31.64M
12.10%-20.67M
20.12%-16.06M
-3.31%-20.07M
12.75%-84.71M
9.33%-21.66M
Operating gains losses
-500.00%-12K
164.04%73K
144.44%8K
-552.94%-154K
-109.22%-20K
95.92%-2K
-375.00%-114K
83.64%-18K
-91.15%34K
149.43%217K
Depreciation and amortization
-68.38%37K
-49.59%61K
-14.40%107K
-3.25%477K
-75.32%114K
182.98%117K
128.30%121K
5.04%125K
-10.53%493K
294.87%462K
Other non cash items
----
----
----
----
----
----
----
----
-87.71%86K
--0
Change In working capital
-224.39%-6.4M
157.50%3.16M
421.60%5.26M
-158.64%-8.27M
-66.91%821K
-130.21%-1.97M
-916.48%-5.49M
-128.96%-1.63M
5,721.91%14.11M
194.69%2.48M
-Change in receivables
59.71%-328K
-25.87%-433K
373.98%2.27M
-170.10%-2.31M
-117.88%-324K
-146.70%-814K
-1,395.65%-344K
-254.70%-830K
-49.53%3.3M
-65.23%1.81M
-Change in prepaid assets
112.72%228K
80.75%-354K
154.63%4.05M
-150.75%-1.35M
225.99%698K
-829.02%-1.79M
-623.93%-1.84M
-47.83%1.59M
144.85%2.65M
14.11%-554K
-Change in payables and accrued expense
-1,091.65%-6.3M
219.27%3.94M
55.50%-1.07M
-156.56%-4.62M
-63.45%447K
-87.24%635K
-280.88%-3.31M
-184.56%-2.39M
1,030.79%8.16M
117.02%1.22M
Cash from discontinued investing activities
Operating cash flow
-32.37%-27.12M
6.58%-18.11M
15.72%-16.36M
-21.13%-75.81M
4.47%-16.53M
-36.13%-20.49M
-16.04%-19.38M
-43.48%-19.41M
20.01%-62.59M
21.22%-17.31M
Investing cash flow
Cash flow from continuing investing activities
-72.76%1.2M
-192.70%-3.7M
-397.11%-39.52M
118.71%13.73M
-911.31%-7.96M
117.33%4.4M
108.14%3.99M
147,900.00%13.3M
-183.86%-73.4M
-96.06%981K
Net PPE purchase and sale
--0
--0
--0
62.70%-47K
--0
--0
121.05%4K
-466.67%-51K
98.96%-126K
74.15%-38K
Net investment purchase and sale
-72.76%1.2M
-192.79%-3.7M
-395.97%-39.52M
118.81%13.78M
-881.06%-7.96M
117.37%4.4M
108.14%3.98M
--13.35M
-173.39%-73.27M
-95.93%1.02M
Cash from discontinued investing activities
Investing cash flow
-72.76%1.2M
-192.70%-3.7M
-397.11%-39.52M
118.71%13.73M
-911.31%-7.96M
117.33%4.4M
108.14%3.99M
147,900.00%13.3M
-183.86%-73.4M
-96.06%981K
Financing cash flow
Cash flow from continuing financing activities
-54.76%266K
-100.35%-46K
13.58%-261K
51.64%86.11M
169,295.35%72.75M
-98.17%588K
-39.47%13.07M
-109.49%-302K
-12.78%56.78M
-100.34%-43K
Net common stock issuance
-77.80%131K
--0
25.19%169K
54.07%86.82M
--72.74M
-98.15%590K
-45.14%13.35M
19.47%135K
-13.37%56.35M
--0
Proceeds from stock option exercised by employees
--139K
--198K
178.69%170K
-88.11%113K
-36.59%52K
--0
--0
-98.09%61K
439.77%950K
7.89%82K
Net other financing activities
-100.00%-4K
14.98%-244K
-20.48%-600K
-59.69%-824K
70.40%-37K
98.10%-2K
-71.86%-287K
-318.49%-498K
-337.29%-516K
---125K
Cash from discontinued financing activities
Financing cash flow
-54.76%266K
-100.35%-46K
13.58%-261K
51.64%86.11M
169,295.35%72.75M
-98.17%588K
-39.47%13.07M
-109.49%-302K
-12.78%56.78M
-100.34%-43K
Net cash flow
Beginning cash position
-44.17%57.17M
-24.55%79.02M
21.62%135.16M
-41.61%111.13M
-31.85%86.9M
-24.65%102.39M
-41.81%104.72M
-41.61%111.13M
64.15%190.34M
-27.10%127.5M
Current changes in cash
-65.54%-25.65M
-837.37%-21.85M
-776.21%-56.14M
130.34%24.03M
394.86%48.26M
-84.64%-15.5M
94.71%-2.33M
38.12%-6.41M
-206.48%-79.2M
-206.03%-16.37M
End cash Position
-63.73%31.52M
-44.17%57.17M
-24.55%79.02M
21.62%135.16M
21.62%135.16M
-31.85%86.9M
-24.65%102.39M
-41.81%104.72M
-41.61%111.13M
-41.61%111.13M
Free cash flow
-32.37%-27.12M
6.56%-18.11M
15.94%-16.36M
-20.96%-75.86M
4.68%-16.53M
-35.59%-20.49M
-15.88%-19.38M
-43.76%-19.46M
30.74%-62.71M
21.59%-17.34M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -32.37%-27.12M6.58%-18.11M15.72%-16.36M-21.13%-75.81M4.47%-16.53M-36.13%-20.49M-16.04%-19.38M-43.48%-19.41M20.01%-62.59M21.22%-17.31M
Net income from continuing operations -10.52%-22.85M-53.42%-24.64M-21.52%-24.39M-4.41%-88.45M-46.08%-31.64M12.10%-20.67M20.12%-16.06M-3.31%-20.07M12.75%-84.71M9.33%-21.66M
Operating gains losses -500.00%-12K164.04%73K144.44%8K-552.94%-154K-109.22%-20K95.92%-2K-375.00%-114K83.64%-18K-91.15%34K149.43%217K
Depreciation and amortization -68.38%37K-49.59%61K-14.40%107K-3.25%477K-75.32%114K182.98%117K128.30%121K5.04%125K-10.53%493K294.87%462K
Other non cash items ---------------------------------87.71%86K--0
Change In working capital -224.39%-6.4M157.50%3.16M421.60%5.26M-158.64%-8.27M-66.91%821K-130.21%-1.97M-916.48%-5.49M-128.96%-1.63M5,721.91%14.11M194.69%2.48M
-Change in receivables 59.71%-328K-25.87%-433K373.98%2.27M-170.10%-2.31M-117.88%-324K-146.70%-814K-1,395.65%-344K-254.70%-830K-49.53%3.3M-65.23%1.81M
-Change in prepaid assets 112.72%228K80.75%-354K154.63%4.05M-150.75%-1.35M225.99%698K-829.02%-1.79M-623.93%-1.84M-47.83%1.59M144.85%2.65M14.11%-554K
-Change in payables and accrued expense -1,091.65%-6.3M219.27%3.94M55.50%-1.07M-156.56%-4.62M-63.45%447K-87.24%635K-280.88%-3.31M-184.56%-2.39M1,030.79%8.16M117.02%1.22M
Cash from discontinued investing activities
Operating cash flow -32.37%-27.12M6.58%-18.11M15.72%-16.36M-21.13%-75.81M4.47%-16.53M-36.13%-20.49M-16.04%-19.38M-43.48%-19.41M20.01%-62.59M21.22%-17.31M
Investing cash flow
Cash flow from continuing investing activities -72.76%1.2M-192.70%-3.7M-397.11%-39.52M118.71%13.73M-911.31%-7.96M117.33%4.4M108.14%3.99M147,900.00%13.3M-183.86%-73.4M-96.06%981K
Net PPE purchase and sale --0--0--062.70%-47K--0--0121.05%4K-466.67%-51K98.96%-126K74.15%-38K
Net investment purchase and sale -72.76%1.2M-192.79%-3.7M-395.97%-39.52M118.81%13.78M-881.06%-7.96M117.37%4.4M108.14%3.98M--13.35M-173.39%-73.27M-95.93%1.02M
Cash from discontinued investing activities
Investing cash flow -72.76%1.2M-192.70%-3.7M-397.11%-39.52M118.71%13.73M-911.31%-7.96M117.33%4.4M108.14%3.99M147,900.00%13.3M-183.86%-73.4M-96.06%981K
Financing cash flow
Cash flow from continuing financing activities -54.76%266K-100.35%-46K13.58%-261K51.64%86.11M169,295.35%72.75M-98.17%588K-39.47%13.07M-109.49%-302K-12.78%56.78M-100.34%-43K
Net common stock issuance -77.80%131K--025.19%169K54.07%86.82M--72.74M-98.15%590K-45.14%13.35M19.47%135K-13.37%56.35M--0
Proceeds from stock option exercised by employees --139K--198K178.69%170K-88.11%113K-36.59%52K--0--0-98.09%61K439.77%950K7.89%82K
Net other financing activities -100.00%-4K14.98%-244K-20.48%-600K-59.69%-824K70.40%-37K98.10%-2K-71.86%-287K-318.49%-498K-337.29%-516K---125K
Cash from discontinued financing activities
Financing cash flow -54.76%266K-100.35%-46K13.58%-261K51.64%86.11M169,295.35%72.75M-98.17%588K-39.47%13.07M-109.49%-302K-12.78%56.78M-100.34%-43K
Net cash flow
Beginning cash position -44.17%57.17M-24.55%79.02M21.62%135.16M-41.61%111.13M-31.85%86.9M-24.65%102.39M-41.81%104.72M-41.61%111.13M64.15%190.34M-27.10%127.5M
Current changes in cash -65.54%-25.65M-837.37%-21.85M-776.21%-56.14M130.34%24.03M394.86%48.26M-84.64%-15.5M94.71%-2.33M38.12%-6.41M-206.48%-79.2M-206.03%-16.37M
End cash Position -63.73%31.52M-44.17%57.17M-24.55%79.02M21.62%135.16M21.62%135.16M-31.85%86.9M-24.65%102.39M-41.81%104.72M-41.61%111.13M-41.61%111.13M
Free cash flow -32.37%-27.12M6.56%-18.11M15.94%-16.36M-20.96%-75.86M4.68%-16.53M-35.59%-20.49M-15.88%-19.38M-43.76%-19.46M30.74%-62.71M21.59%-17.34M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Broadcom
AVGO
+2.37%
Alibaba
BABA
+0.65%
Adobe
ADBE
+0.50%
Apple
AAPL
+0.32%
Cisco
CSCO
+0.22%

Unlock the Full List

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-0.12%